Alpine Immune Sciences
Immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions. Learn more
Launch date
Employees
Market cap
AUD6.9b
Enterprise valuation
AUD6.3b (Public information from May 2024)
Share price
$64.97 ALPN
Seattle Washington (HQ)
Authorizing premium user...